论文部分内容阅读
目的:调查老年非小细胞肺肿瘤(NSCLC)患者贫血的发生率及临床输血情况,探讨老年NSCLC患者的输血现状及临床的重视程度。方法:收集232例老年NSCLC患者和肺良性病变患者50例,根据《AJCC肿瘤分期手册》标准对老年NSCLC患者进行分期(其中Ⅰ期87例、Ⅱ期45例、Ⅲ期71例、Ⅳ期29例),收集所有患者住院期间的血常规结果及输血情况。结果:老年NSCLC患者的输血比例远高于肺良性病变患者;随着老年NSCLC患者肿瘤恶性程度的增加,贫血的发生率在增加,但输血的比例没有随之增加;老年NSCLC患者的输血以红细胞输注为主,各期老年NSCLC患者之间成分输血没有差异。结论:老年NSCLC患者在输血时以输注红细胞为主,输血比例与肿瘤的分期无关,提示临床为了改善老年NSCLC患者的生存、生活质量,应更加关注Ⅲ、Ⅳ期老年NSCLC患者的输血。
Objective: To investigate the incidence of anemia and clinical transfusion in elderly patients with non-small cell lung cancer (NSCLC) and to investigate the status of transfusion and the clinical importance of NSCLC. Methods: A total of 232 elderly patients with NSCLC and 50 patients with benign lung diseases were collected. The patients were divided into two groups according to the criteria of AJCC Staging Manual (87 cases in stage Ⅰ, 45 cases in stage Ⅱ, 71 cases in stage Ⅲ, Cases), collect all patients during hospital blood routine results and blood transfusion. Results: The proportion of blood transfusions in elderly patients with NSCLC was much higher than that in patients with benign lung disease. With the increase of the degree of malignancy in elderly NSCLC patients, the incidence of anemia increased, but the proportion of transfusions did not increase. Infusion based, there is no difference between the components of blood transfusion between the elderly NSCLC patients. CONCLUSIONS: In elderly patients with NSCLC, transfusion of erythrocytes is the mainstay. The proportion of blood transfusion is not related to the stage of the tumor, suggesting that in order to improve the quality of life and the quality of life of elderly patients with NSCLC, more attention should be paid to the transfusion of elderly patients with stage Ⅲ and Ⅳ NSCLC.